You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics

Article metrics

Article menu
Basic tumor immunology
Original research
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics

 

Online download statistics by month:

Online download statistics by month: July 2022 to February 2026

AbstractFullPdf
Jul 2022518528156
Aug 2022415425135
Sep 202251052667
Oct 202218118260
Nov 202213814144
Dec 202217617748
Jan 2023878936
Feb 2023939648
Mar 2023747451
Apr 2023878747
May 2023585939
Jun 2023818134
Jul 2023525227
Aug 2023636333
Sep 2023505018
Oct 2023565626
Nov 2023525230
Dec 2023464637
Jan 2024505127
Feb 2024595950
Mar 2024656584
Apr 2024525223
May 2024888851
Jun 2024616031
Jul 2024838432
Aug 2024514853
Sep 2024949433
Oct 2024767632
Nov 2024636532
Dec 2024939533
Jan 2025686826
Feb 202518518525
Mar 2025838335
Apr 2025747431
May 2025535330
Jun 2025373819
Jul 2025110
Feb 2026110
Total407441241583